Viral and Immune Risk Factors of HIV Rebound After Interruption of Antiretroviral Therapy
These findings underscore the importance of early ART initiation and suggest that tailored interventions based on virologic, immunologic, and demographic factors may help achieve sustained viral suppression. Clinical Trials Registration. NCT00537966 and NCT03001128.
Authors
- Merle Schanz
- Noah C. Gaitan (ORCID: https://orcid.org/0009-0001-8413-3497)
- Tingting Yu (ORCID: https://orcid.org/0000-0002-1628-5819)
- Antoine Chaillon (ORCID: https://orcid.org/0000-0001-9490-3857)
- Herbert Kuster (ORCID: https://orcid.org/0000-0001-6873-0091)
- Gemma Caballero
- Jonathan Z. Li (ORCID: https://orcid.org/0000-0001-9914-9662)
- Rajesh T. Gandhi (ORCID: https://orcid.org/0000-0002-9701-6062)
- Karin J. Metzner (ORCID: https://orcid.org/0000-0003-4862-1503)
- Stephen A. Rawlings (ORCID: https://orcid.org/0000-0003-3637-1447)
- Huldrych F. Günthard (ORCID: https://orcid.org/0000-0002-1142-6723)
- Roger D. Kouyos (ORCID: https://orcid.org/0000-0002-9220-8348)
- David M. Smith (ORCID: https://orcid.org/0000-0002-0542-5759)
- Sara Gianella (ORCID: https://orcid.org/0000-0002-9927-0849)
- C. Ignacio
- Ran Wang (ORCID: https://orcid.org/0009-0004-3675-5103)
Institutions
- Tufts University (US)
- Brigham and Women's Hospital (US)
- Harvard University (US)
- University of Zurich (CH)
- University of California System (US)
- University of California San Diego (US)
- Massachusetts General Hospital (US)
- University Hospital of Zurich (CH)
- Cancer Research And Biostatistics (US)
- Harvard Pilgrim Health Care (US)
- Maine Medical Center (US)
Publication Details
- Journal
- The Journal of Infectious Diseases
- Published
- 2024-12-11
- DOI
- https://doi.org/10.1093/infdis/jiae585
- Citations
- 2
- Primary Topic
- HIV Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.59